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Abstract
Background: In response to concerns expressed by workers at a public meeting, we analyzed the
mortality experience of workers who were employed at the IBM plant in Endicott, New York and
died between 1969–2001. An epidemiologic feasibility assessment indicated potential worker
exposure to several known and suspected carcinogens at this plant.
Methods: We used the mortality and work history files produced under a court order and used
in a previous mortality analysis. Using publicly available data for the state of New York as a standard
of comparison, we conducted proportional cancer mortality (PCMR) analysis.
Results: The results showed significantly increased mortality due to melanoma (PCMR = 367; 95%
CI: 119, 856) and lymphoma (PCMR = 220; 95% CI: 101, 419) in males and modestly increased
mortality due to kidney cancer (PCMR = 165; 95% CI: 45, 421) and brain cancer (PCMR = 190; 95%
CI: 52, 485) in males and breast cancer (PCMR = 126; 95% CI: 34, 321) in females.
Conclusion: These results are similar to results from a previous IBM mortality study and support
the need for a full cohort mortality analysis such as the one being planned by the National Institute
for Occupational Safety and Health.
Background
There have been a number of recent studies of cancer inci-
dence [1] and mortality [2] and other health outcomes in
workers in the semiconductor and computer manufactur-
ing industries. Some of these have focused on workers in
a particular plant or group of similar plants and one [3]
examined the mortality experience of employees at multi-
ple plants for a large company. The exposures vary at these
manufacturing and fabrication facilities, and they have
changed over time as the technology and work processes
have developed or become automated [4]. The meaning
and significance of these studies have been discussed in
review articles and commentaries [5-7].
Another concern that has arisen is pollution in a commu-
nity near an IBM manufacturing plant in Endicott, NY.
This has resulted in an evaluation of trichloroethylene in
groundwater and vapor intrusion into the basements of
nearby homes and businesses. Attention to this source of
exposure has led employees of this IBM plant to request a
study of cancer and other health effects in former workers.
Although this plant was one of the original IBM manufac-
turing plants and a variety of products were made there
over the past several decades, the most recent activities
were the production of printed circuit boards. It therefore
had some chemical and physical exposures that were sim-
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ilar to other manufacturing facilities, including the IBM
San Jose plant.
In response to concerns expressed by employees, we con-
ducted a supplementary analysis of data from a previous
publication on mortality among the U.S. employees of the
IBM company [3]. One of us (RWC) attended a meeting
in the community near the plant in Endicott, NY and
heard the concerns from former IBM employees in the
audience about cancer in workers, in particular. This
former IBM facility had produced a variety of products
since it began operations in 1911, including calculating
machines, typewriters, guns, printers, automated
machines for banks, printed circuit boards and chip pack-
aging. The purpose of the supplementary analysis of mor-
tality data for this plant was to see if there were patterns of
cancer mortality similar to those seen in other IBM man-
ufacturing workers during the years 1969–2001. IBM sold
the Endicott microelectronics facility in 2002.
Methods
The present supplementary analysis was carried out in
response to workers' desires for information. It is based on
the IBM Corporate Mortality File (CMF) which was pro-
duced after a court order during litigation and used in a
previous analysis, but which did not look at the Endicott
plant workers separately. The CMF contained records for
deceased individuals who had been employed in an IBM
facility for five years or more, who were actively employed
or receiving retirement or disability benefits at time of
death, and whose families had filed a claim for death ben-
efits in their Corporate Mortality File (CMF). Within the
CMF, underlying causes of death were coded to the Ninth
Revision of the International Classification of Disease
(ICD 9). As in the previous study, data from the CMF were
joined to work history data from the IBM Corporate
Employee Resource Information System (CERIS) that
included a location code for place of employment. Death
records of individuals who had worked at Endicott
between 1969 and 2001 were selected using seven loca-
tion codes that were associated with the facility over time.
Proportional cancer mortality (PCMR) analysis [8] was
conducted using publicly available data for the state of
New York as a standard of comparison [9]. Unfortunately,
state cancer mortality data could not be located for the
entire study period; however, comparison data for the
years 1979 to 1998 were used in the PCMR analyses. Pro-
portional cancer mortality ratios were calculated from the
ratio of the observed number of deaths due to a particular
cancer type among the workers to the expected number of
deaths of that type in each sex. For each PCMR, 95% Pois-
son confidence intervals were also calculated.
Results
From the CMF and CERIS files, we identified 360 Endicott
employee deaths. Of these, 115 deaths were attributable
to cancer. The number of cancer deaths by age group and
sex is presented in Table 1; the number of deaths by cancer
type and sex is presented in Table 2.
The PCMR results for those cancer types with at least four
deaths in one sex are presented in Table 3. The full analy-
sis is provided as an appendix [see Additional file 1]. Mor-
tality due to melanoma (PCMR = 367; 95% CI: 119, 856)
and lymphoma (PCMR = 220; 95% CI: 101, 419) were
significantly increased in males. Modestly increased mor-
tality due to kidney cancer (PCMR = 165; 95% CI: 45,
421) and brain cancer (PCMR = 190; 95% CI: 52, 485) in
males were also observed. In females, a modest increase in
breast cancer (PCMR = 126; 95% CI: 34, 321) was
observed.
Discussion
Our results, although based on a small number of deaths,
suggest an increased risk of several types of cancer among
employees of the Endicott facility. According to a NIOSH
feasibility study [10] completed over a year ago, there
were 28,000 workers employed at the Endicott plant for at
least a year after 1965. A large percentage (44%) were
potentially exposed to one or more carcinogens, including
asbestos, benzene, cadmium, nickel compounds, vinyl
chloride or probable carcinogens such as tetrachloroethyl-
ene, trichloroethylene, PCBs, ortho-toluidine and ultravi-
olet light. A variety of other solvents were used, and
chlorinated solvents were eventually phased out begin-
ning in the 1980s. NIOSH has concluded that a cohort
study of the Endicott employees is feasible and is currently
developing a protocol to conduct the study.
Other studies of workers in the semiconductor and com-
puter manufacturing industry are underway in the U.S.
and Europe. The literature to date is quite sparse, and it is
anticipated that these new studies will shed additional
light on risks of cancer and other diseases in this impor-
tant international industry. The challenge will be to eval-
uate exposures as they change over time and incorporate
this information into epidemiologic analyses of subse-
quent health risks. Safer materials and production meth-
Table 1: Endicott cancer deaths by age and sex.
Age Group Females Males
35–44 years 11
45–54 years 11 5
55–64 years 62 8
65–74 years 65 5
75–84 years 11Environmental Health 2008, 7:13 http://www.ehjournal.net/content/7/1/13
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ods appear to be needed irrespective of the ultimate
outcome of the studies.
Conclusion
This mortality analysis updates previous results presented
for all IBM employees and for sub-groups of manufactur-
ing workers and workers at other specific plants. In the
present analysis, several types of cancer were elevated as a
cause of death in Endicott workers, compared to deaths in
New York State during the same time period. The PCMR
results in Table 3 show significantly elevated mortality
due to melanoma and lymphoma, and elevated but not
significant mortality due to breast cancer, kidney cancer
and brain cancer. These results are similar to the results
seen in IBM manufacturing plants such as the San Jose, CA
plant in previous analyses.
These results are based on small numbers of deaths, and
they do not include deaths in workers who were not eligi-
ble to be in the Corporate Mortality File. The similarity in
the pattern of mortality and the similarity in some of the
chemical exposures in the Endicott plant suggest that
there may be more information to be learned from a full
cohort study such as the one being proposed by NIOSH.
Table 2: Endicott cancer deaths by type and sex.
Females Males
All Cancers 15 100
Bladder 01
Brain 04
Breast 41
Colon 07
Endocrine Glands 01
Esophagus 14
Gallbladder 12
Kidney 04
Larynx 10
Liver 01
Lung 33 5
Lymphoma 09
Melanoma 05
Multiple Myeloma 03
Nasal cavities, middle ear, and accessory sinuses 01
Nasopharynx 10
Oropharynx 01
Ovary 10
Pancreas 14
Rectum 13
Stomach 04
Without Specific Site 11 0
Table 3: Endicott cancer PCMRs by type and sex.
Males Females
Observed Expected PCMR Lower C.I. Upper C.I. Observed Expected PCMR Lower C.I. Upper C.I.
All Cancers 100 100.0 - - - 15 15.0 - - -
Esophagus 4 3.6 111.6 30.3 285.6 1 0.2 524.0 13.3 2918
Stomach 4 3.9 102.8 33.3 239.5 0 - - - -
Colon 7 9.6 72.6 29.1 149.6 0 - - - -
Pancreas 4 5.3 76.0 20.7 194.6 1 0.8 132.7 3.4 739.1
Lung 35 34.2 102.5 71.4 142.4 3 3.2 94.7 19.5 276.6
Melanoma 5 1.4 367.3 119.0 855.7 0 - - - -
Breast 1 0.1 728.0 18.4 4054 4 3.2 125.5 34.1 321.3
Kidney 4 2.4 164.5 44.7 421.1 0 - - - -
Brain 4 2.1 189.5 51.6 485.2 0 - - - -
All 
Lymphoma
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